Related Experiment Video
Updated: Jun 27, 2026

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
Published on: June 3, 2018
Return to the past: myocardial regeneration therapy
1Clínica Universitária de Cardiologia, Faculdade de Medicina de Coimbra, Coimbra, Portugal. lgoncal@ci.uc.pt
Abstract:
In recent years, myocardial regeneration therapy has been the subject of intense research. Several different cell lines and routes of administration have been tested and the main mechanisms of action are known. A substantial amount of data is available not only from the bench, but also from the bedside. However, there are still many unanswered questions about the safety and efficacy of this treatment The future of this therapy is uncertain at present, but it unquestionably has great potential. We await the results of ongoing clinical trials in order to have a clearer view of this field of research.
Insights
Myocardial regeneration therapy shows promise for heart repair, with various cell types and delivery methods explored. Further clinical trials are needed to confirm the safety and efficacy of these innovative cardiac treatments.
Area of Science:
- Cardiovascular Research
- Regenerative Medicine
- Cell-Based Therapies
Background:
- Myocardial regeneration therapy is under intense investigation for cardiac repair.
- Extensive research has explored different cell lines and administration routes.
- Understanding of the primary mechanisms of action is established.
Purpose of the Study:
- To review the current state of myocardial regeneration therapy.
- To highlight the available data from preclinical and clinical studies.
- To identify remaining questions regarding treatment safety and efficacy.
Main Methods:
- Review of existing scientific literature and clinical data.
- Analysis of preclinical research (bench data).
- Evaluation of clinical findings (bedside data).
Main Results:
- Multiple cell types and delivery methods have been tested for myocardial regeneration.
- Key mechanisms of action for these therapies are largely understood.
- Significant data exists from both laboratory and clinical settings.
Conclusions:
- Despite considerable progress, critical questions about safety and efficacy persist.
- The future of myocardial regeneration therapy remains uncertain but holds great potential.
- Ongoing clinical trials are essential to clarify the therapeutic landscape.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Myocarditis III: Medical Management

